Repros Therapeutics, Inc. (RPRX) Tops Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $59.45 +1.45%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q4 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $1 thousand.
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Wendy's U.S. president to resign, company to create COO role
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
